A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen.

Completed

Conditions studied: Adenocarcinoma

In brief

A retrospective and prospective data collection study on 27 consecutive subjects with adenocarcinoma who were treated using the MyVaccx system by Dr. Gary Onik. Retrospective data were collected on the treatment with the immunotherapy system and prospective data will be collected as they are prospectively monitored through their normal standard of care for their original cancer.

Key facts

Study ID

NCT03695835

Run by

Gary Onik MD

People needed

27

Starts

2018-04-11

Expected to finish

2020-06-17

Last updated by the study team

2020-07-22

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Treatment with the MyVaccx System
• Greater than 18 years of age
• Signature of the informed consent

You may not qualify if…

• 2 subjects treated with the MyVaccx System with known visceral disease

Where it is running

• The Center for High Risk and Recurrent Prostate Cancer — Fort Lauderdale, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.